A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
Clinical trial NCT07475806 · RECRUITING
Trial details
- NCT number
- NCT07475806
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-12
- Primary completion
- 2027-11-30
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.